melanoma has been guided by many multicenter randomized trials that have shaped management decisions. Treatment has evolved from elective lymph node dissections to newer strategies identifying the most at-risk patients through sentinel lymph node (SLN
Elizabeth G. Grubbs and Douglas B. Evans
extensive lymph node dissection: metastatic lymph nodes in papillary carcinoma of the thyroid] . Nippon Geka Gakkai Zasshi 1986 ; 87 : 883 – 888 [in Japanese] . 5. Tisell LE Nilsson B Molne J . Improved survival of patients with papillary
Nawin Kuntaraksa
Objective: The primary objective was to evaluate seroma formation in a comparison between the lymphatic ligation technique and conventional axillary lymph node dissection. The secondary objective was to evaluate the factors affecting seroma
James Sun, Brittany J. Mathias, Christine Laronga, Weihong Sun, Jun-Min Zhou, William J. Fulp, John V. Kiluk and M. Catherine Lee
Background Surgical management of invasive breast cancer has moved toward less-invasive measures, including axillary management. Axillary lymph node dissection is associated with significant morbidity and complications (wound infections, seromas
Donglai Chen, Yiming Mao, Junmiao Wen, Jian Shu, Fei Ye, Yunlang She, Qifeng Ding, Li Shi, Tao Xue, Min Fan, Yongbing Chen and Chang Chen
-specific lymph node dissection (LSD) is equivalent to SLND in early-stage NSCLC. 14 , 16 , 17 Therefore, it is important to determine the threshold of ELNs and ENSs for early-stage NSCLC, especially for radiologically pure-solid NSCLC. To address these
Donglai Chen, Yiming Mao, Junmiao Wen, Jian Shu, Fei Ye, Yunlang She, Qifeng Ding, Li Shi, Tao Xue, Min Fan, Yongbing Chen and Chang Chen
based on several studies suggested that lobe-specific lymph node dissection (LSD) is equivalent to SLND in early-stage NSCLC. 14 , 16 , 17 Therefore, it is important to determine the threshold of ELNs and ENSs for early-stage NSCLC, especially for
Anthony J. Olszanski
biopsy. After a diagnosis of stage III disease based on SLN biopsy, the previous version of the NCCN Guidelines stated that these patients should undergo complete lymph node dissection (CLND). “’The questions we had to ask were, ‘Is that something we
Anupam Rishi, Jordan McDonald, Sabrina Saeed, Rutika Mehta, David Pointer, Jessica Frakes, Sarah Hoffe, Jacques Fontaine and Jose Pimiento
Jaffer A. Ajani, David J. Bentrem, Stephen Besh, Thomas A. D’Amico, Prajnan Das, Crystal Denlinger, Marwan G. Fakih, Charles S. Fuchs, Hans Gerdes, Robert E. Glasgow, James A. Hayman, Wayne L. Hofstetter, David H. Ilson, Rajesh N. Keswani, Lawrence R. Kleinberg, W. Michael Korn, A. Craig Lockhart, Kenneth Meredith, Mary F. Mulcahy, Mark B. Orringer, James A. Posey, Aaron R. Sasson, Walter J. Scott, Vivian E. Strong, Thomas K. Varghese Jr, Graham Warren, Mary Kay Washington, Christopher Willett, Cameron D. Wright, Nicole R. McMillian and Hema Sundar
second most common cause of cancer-related death worldwide. In 2013, an estimated 21,600 new cases will be diagnosed and 10,990 people will die of the disease in United States. 1 Surgery with lymph node dissection is the primary treatment for patients
William C. Huang and Bernard H. Bochner
Gschwend JE Herr HW . Pelvic lymph node dissection can be curative in patients with node positive bladder cancer . J Urol 1999 ; 161 : 449 – 454 . 7. Leissner J Ghoneim MA Abol-Enein H . Extended radical lymphadenectomy in patients with
